2016-02-03T12:58:48Z
2016-02-03T12:58:48Z
2015-04-16
2016-02-03T12:58:48Z
In the last decade we have witnessed a dramatic increase in the proportion and absolute number of bacterial pathogens resistant to multiple antibacterial agents. Multidrug-resistant bacteria are currently considered as an emergent global disease and a major public health problem. The B-Debate meeting brought together renowned experts representing the main stakeholders (i.e. policy makers, public health authorities, regulatory agencies, pharmaceutical companies and the scientific community at large) to review the global threat of antibiotic resistance and come up with a coordinated set of strategies to fight antimicrobial resistance in a multifaceted approach. We summarize the views of the B-Debate participants regarding the current situation of antimicrobial resistance in animals and the food chain, within the community and the healthcare setting as well as the role of the environment and the development of novel diagnostic and therapeutic strategies, providing expert recommendations to tackle the global threat of antimicrobial resistance.
Article
Published version
English
Resistència als medicaments; Antibiòtics; Administració de medicaments; Bacteris patògens; Utilització de medicaments; Salut pública; Drug resistance; Antibiotics; Administration of drugs; Pathogenic bacteria; Drug utilization; Public health
European Society of Clinical Microbiology and Infectious Diseases
Reproducció del document publicat a: http://dx.doi.org/10.1016/j.nmni.2015.02.007
New Microbes and New Infections, 2015, vol. 6, p. 22-29
http://dx.doi.org/10.1016/j.nmni.2015.02.007
cc-by-nc-nd (c) Roca et al., 2015
http://creativecommons.org/licenses/by-nc-nd/3.0/es